Patterns of cytokine production in human immunodeficiency virus type 1 (HIV-1)-specific human CD8+ T cells after stimulation with HIV-1-infected CD4+ T cells

Journal of Virology

Volumn 79, Issue 19, 2005, Pages 12536-12543

  Fujiwara, Mamoru ^a   Takata, Hiroshi ^a   Oka, Shinichi ^b   Tomiyama, Hiroko ^a   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CLONE; CELL ISOLATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMORY CELL; MOLECULAR RECOGNITION; PHENOTYPE; PRIORITY JOURNAL; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HIV-1; HUMANS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 25144515977     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.19.12536-12543.2005     Document Type: Article

References (28)

1. Akari, H., S. Arold, T. Fukumori, T. Okazaki, K. Strebel, and A. Adachi. 2000. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74:2907-2912.
2. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955-1958.
3. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotype analysis of antigen-specific T lymphocytes. Science 274:94-96.
4. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75.
5. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379-385.
6. + T cells. Science 270:1811-1815.
7. Collins, K. L., and D. Baltimore. 1999. HIVs evasion of the cellular immune response. Immunol. Rev. 168:65-74.
8. Dayton, E. T., M. Matsumoto-Kobayashi, B. Perussia, and G. Trinchieri. 1985. Role of immune Interferon in the monocytic differentiation of human promyelocytic cell lines induced by leukocyte conditioned medium. Blood 66:583-594.
9. + T lymphocytes in healthy seropositive donors. J. Virol. 74:8140-8150.
10. Guidotti, L. G., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8:478-483.
11. Reference deleted.
12. Reference deleted.
13. Hossain, M. S., H. Tomiyama, T. Inagawa, B. Wriwanthana, S. Oka, and M. Takiguchi. 2001. HLA-A*3303-restricted cytotoxic T lymphocyte recognition for novel epitopes derived from the highly variable region of the HIV-1 Env protein. AIDS 15:2199-2201.
14. Ikeda-Moore, Y., H. Tomiyama, M. Ibe, S. Oka, K. Miwa, Y. Kaneko, and M. Takiguchi. 1998. Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope derived from HIV-1 Gag protein. AIDS 12:2073-2074.
15. Kurane, I., A. Meager, and A. E. Francis. 1989. Dengue virus-specific human T cell clones: serotype crossreactive proliferation, interferon-γ production, and cytotoxic activity. J. Exp. Med. 170:763-775.
16. + influenza virus-specific CTL clone. Viral Immunol. 6:1-11.
17. + T cells. Immunol. Today 17:217-224.
18. Liu, C. C., C. M. Walsh, and J. D. Young. 1995. Perform: structure and function. Immunol. Today 16:194-201.
19. Okamoto, M., M. Makino, I. Kitajima, I. Maruyama, and M. Baba. 1997. HIV-1-infected myelomonocytic cells are resistant to Fas-mediated apoptosis: effect of tumor necrosis factor-alpha on their Fas expression and apoptosis. Med. Microbiol. Immunol. 186:11-17.
20. + T lymphocytes. J. Immunol. 167:181-187.
21. Shiga, H., T. Shioda, H. Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi, T. Gojoubori, H. G. Rammensee, K. Miwa, and M. Takiguchi. 1996. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 10:1075-1083.
22. + T-cell cytolytic activity and cytokine production. J. Virol. 76:7535-7543.
23. + T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur. J. Immunol. 34:999-1010.
24. + T cells in chronically HIV-1 infected individuals. AIDS 14:2049-2051.
25. + T cells from a memory to memory/effector phenotype. J. Immunol. 168:5538-5550.
26. Trapani, J. A., V. R. Sutton, and M. J. Smyth. 1999. CTL granule: evolution of vesicles essential for combating virus infections. Immunol. Today 20:351-356.
27. Vegh, Z., P. Wang, F. Vanky, and E. Klein. 1993. Increased expression of MHC class 1 molecules on human cells after short time IFN-γ treatment. Mol. Immunol. 30:849-854.
28. + cells: evidence for HLA class-I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120-3128.